PTC Therapeutics reported 8.76 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Acadia Pharmaceuticals 11.33 1.25 Jun/2026
Alnylam Pharmaceuticals 75.64 4.4 Jun/2026
Amgen 18.07 1.77 Jun/2026
BioCryst Pharmaceuticals 6.84 0.78 Jun/2026
Biogen 23.23 9.53 Jun/2026
BioMarin Pharmaceutical 21.07 5.79 Jun/2026
Daiichi Sankyo 20.14 0.6 Jun/2026
Gilead Sciences 13.51 4.2 Jun/2026
Incyte 14.45 0.9 Jun/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Ironwood Pharmaceuticals 204.24 88.19 Dec/2024
Novartis 22.41 2.24 Jun/2026
Pfizer 11.48 2.16 Jun/2026
PTC Therapeutics 8.76 1.22 Mar/2026
Puma Biotechnology 13.93 44.88 Jun/2024
Roche Holding 16.48 0.39 Jun/2026
Sarepta Therapeutics 27.27 0 Mar/2026
TG Therapeutics 19.64 7.65 Jun/2026
Vertex Pharmaceuticals 28.05 2.22 Jun/2026
Xencor 29.92 3.22 Sep/2022